Header Logo

Connection

JOSEPH ROYS to Neuroendocrine Tumors

Back to Details
This is a "connection" page, showing publications JOSEPH ROYS has written about Neuroendocrine Tumors.
JOSEPH ROYS
Connection Strength
0.137
Neuroendocrine Tumors
  1. Peptide Receptor Radionuclide Therapy With 177Lu-Octreotate in Patients With Somatostatin Receptor Expressing Neuroendocrine Tumors: Six Years' Assessment. Clin Nucl Med. 2017 Jun; 42(6):436-443.
    View in: PubMed
    Score: 0.137
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.